{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:41:56Z","timestamp":1790912516951,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"46","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T00:00:00Z","timestamp":1558310400000},"content-version":"vor","delay-in-days":200,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014588","name":"Sanofi Pasteur","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100014588","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009947","name":"Merck Sharp & Dohme","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.vaccine.2018.08.037","type":"journal-article","created":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T12:13:17Z","timestamp":1536149597000},"page":"7105-7111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Assessing the effectiveness of zoster vaccine live: A retrospective cohort study using primary care data in the United Kingdom"],"prefix":"10.1016","volume":"36","author":[{"given":"Ian","family":"Matthews","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazel","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Bricout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"O'Hanlon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bayad","family":"Nozad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.08.037_b0005","doi-asserted-by":"crossref","unstructured":"Serpell M. Burden of post-herpetic neuralgia in a sample of UK residents aged 50 years or older: findings from the zoster quality of life (ZQOL) study. BioMed Cent [Internet]. 2013 Dec; Available from: https:\/\/hqlo.biomedcentral.com\/articles\/10.1186\/1477-7525-12-92.","DOI":"10.1186\/1477-7525-12-92"},{"key":"10.1016\/j.vaccine.2018.08.037_b0010","unstructured":"Shingles - NICE CKS [Internet]. [cited 2017 Nov 8]. Available from: https:\/\/cks.nice.org.uk\/shingles#!backgroundsub."},{"key":"10.1016\/j.vaccine.2018.08.037_b0015","unstructured":"Shingles (herpes zoster) [Internet]. Green Book. 2016 [cited 2017 Sep 11]. Available from: https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/503773\/2905109_Green_Book_Chapter_28a_v3_0W.PDF."},{"issue":"4","key":"10.1016\/j.vaccine.2018.08.037_b0020","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/00013542-199310000-00006","article-title":"Epidemiology, outcome and control of varicella-zoster infection","volume":"4","author":"Miller","year":"1993","journal-title":"Rev Med Microbiol"},{"issue":"13","key":"10.1016\/j.vaccine.2018.08.037_b0025","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/1471-2334-13-170","article-title":"Similar herpes zoster incidence across Europe: results from a systematic literature review","volume":"10","author":"Pinchinat","year":"2013","journal-title":"BMC Infect Dis"},{"issue":"22","key":"10.1016\/j.vaccine.2018.08.037_b0030","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.vaccine.2018.08.037_b0035","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.vaccine.2008.12.024","article-title":"Estimating the cost-effectiveness of vaccination against herpes zoster in England and Wales","volume":"27","author":"van Hoek","year":"2009","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2018.08.037_b0040","unstructured":"Shingles | Clinical Overview - Varicella Vaccine | Herpes Zoster | CDC [Internet]. 2017 [cited 2017 Nov 23]. Available from: https:\/\/www.cdc.gov\/shingles\/hcp\/clinical-overview.html."},{"issue":"12","key":"10.1016\/j.vaccine.2018.08.037_b0045","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/01.ASW.0000323588.19981.28","article-title":"Herpes zoster: prevention, diagnosis, and treatment--2008 update","volume":"21","author":"Wilson","year":"2008","journal-title":"Adv Skin Wound Care"},{"issue":"3","key":"10.1016\/j.vaccine.2018.08.037_b0050","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.cger.2007.03.003","article-title":"Herpes zoster and postherpetic neuralgia in older adults","volume":"23","author":"Schmader","year":"2007","journal-title":"Clin Geriatr Med"},{"issue":"6","key":"10.1016\/j.vaccine.2018.08.037_b0055","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/cid\/ciw854","article-title":"Effectiveness and duration of protection provided by the live-attenuated herpes zoster vaccine in the medicare population ages 65 years and older","volume":"64","author":"Izurieta","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2018.08.037_b0060","doi-asserted-by":"crossref","unstructured":"Ansaldi F. Real-world effectiveness and safety of a live-attenuated herpes zoster vaccine: A comprehensive review. Adv Ther [Internet]. 2016 Jun;33. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4939147\/.","DOI":"10.1007\/s12325-016-0355-0"},{"key":"10.1016\/j.vaccine.2018.08.037_b0065","unstructured":"Herpes zoster (shingles) immunisation programme 2013\/2014: Report for England [Internet]. Public Health England. [cited 2017 Sep 11]. Available from: https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/383018\/ShinglesReport2014.pdf."},{"issue":"17","key":"10.1016\/j.vaccine.2018.08.037_b0070","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1016\/j.vaccine.2018.02.021","article-title":"Effectiveness of herpes zoster vaccination in an older United Kingdom population","volume":"36","author":"Walker","year":"2018","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2018.08.037_b0075","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/ije\/dym021","article-title":"Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness","volume":"36","author":"Orenstein","year":"2007","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2018.08.037_b0080","unstructured":"UCL, Rowl, Street H, Nw3 2pf, Tel: +4420 7830 2239 L. THIN Database [Internet]. [cited 2017 Nov 9]. Available from: https:\/\/www.ucl.ac.uk\/pcph\/research-groups-themes\/thin-pub\/database."},{"key":"10.1016\/j.vaccine.2018.08.037_b0085","first-page":"251","article-title":"Generalisability of The Health Improvement Network (THIN) database: demographics, chronic disease prevalence and mortality rates","volume":"19","author":"Blak","year":"2011","journal-title":"Inform Prim Care"},{"key":"10.1016\/j.vaccine.2018.08.037_b0090","unstructured":"Principles of Epidemiology | Lesson 3 - Section 6 [Internet]. [cited 2017 Nov 2]. Available from: https:\/\/www.cdc.gov\/ophss\/csels\/dsepd\/ss1978\/lesson3\/section6.html."},{"key":"10.1016\/j.vaccine.2018.08.037_b0095","doi-asserted-by":"crossref","unstructured":"Oxman MN, Levin MJ, Shingles Prevention Study Group. Vaccination against Herpes Zoster and Postherpetic Neuralgia. J Infect Dis. 2008 Mar 1;197 Suppl 2:S228\u2013236.","DOI":"10.1086\/522159"},{"issue":"1","key":"10.1016\/j.vaccine.2018.08.037_b0100","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1017\/S0950268808000678","article-title":"Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom","volume":"137","author":"Gauthier","year":"2009","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2018.08.037_b0105","doi-asserted-by":"crossref","unstructured":"Alexandridou M, Bollaerts K. Zoster vaccine effectiveness against herpes zoster and poste-herpetic neuralgia and risk factors for vaccine failure among elderly in England. Poster presented at: ISPOR 20th Annual European Congress; 2017 Nov.","DOI":"10.1016\/j.jval.2017.08.2263"},{"key":"10.1016\/j.vaccine.2018.08.037_b0110","first-page":"1","article-title":"long-term effectiveness of the live zoster vaccine in preventing shingles: A Cohort study","author":"Baxter","year":"2017","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2018.08.037_b0115","unstructured":"Amirthalingam G. Evaluation of the effect of the herpes zoster vaccination programme 3 years after its introduction in England: a population-based study [Internet]. 2017 [cited 2018 Jan 9]. Available from: http:\/\/www.thelancet.com\/pdfs\/journals\/lanpub\/PIIS2468-2667(17)30234-7.pdf."},{"issue":"12","key":"10.1016\/j.vaccine.2018.08.037_b0120","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.4065\/mcp.2011.0305","article-title":"Herpes zoster and postherpetic neuralgia surveillance using structured electronic Data","volume":"86","author":"Klompas","year":"2011","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.vaccine.2018.08.037_b0125","doi-asserted-by":"crossref","unstructured":"Kawai K, Gebremeskel BG, Acosta CJ. Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open [Internet]. 2014 Jun 10 [cited 2017 Dec 15];4(6). Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4067812\/.","DOI":"10.1136\/bmjopen-2014-004833"},{"key":"10.1016\/j.vaccine.2018.08.037_b0130","unstructured":"Shingles vaccine coverage report, England, September 2015 to February 2016 [Internet]. Public Health England; 2016 May [cited 2017 Sep 12]. Available from: https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/521577\/hpr1616_shngls-VC.pdf."},{"key":"10.1016\/j.vaccine.2018.08.037_b0135","unstructured":"Shingles vaccine coverage report, England, September 2016 to February 2017 [Internet]. Public Health England; 2017 Apr. Available from: https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/611730\/hpr1617_shngls-vc.pdf."},{"key":"10.1016\/j.vaccine.2018.08.037_b0140","unstructured":"Vaccine Update [Internet]. [cited 2018 Jan 16]. Available from: https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/669418\/VU_273_December2017.pdf."},{"key":"10.1016\/j.vaccine.2018.08.037_b0145","doi-asserted-by":"crossref","unstructured":"Abdalrahman B, Laverty AA, Beckett G, Majeed A. Trends in hospital admissions for Varicella and Zoster viruses in England, 2001\/2002\u20132010\/2011: time trend study. JRSM Open [Internet]. 2015 Jan 19;6(1). Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4304893\/.","DOI":"10.1177\/2054270414562984"},{"key":"10.1016\/j.vaccine.2018.08.037_b0150","unstructured":"Wijlaars L. THIN Data: Strengths & Limitations [Internet]. UCL; 2013 May. (THIN Database Research Team). Available from: http:\/\/www.ucl.ac.uk\/pcph\/research-groups-themes\/thin-pub\/."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18311666?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18311666?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T22:17:31Z","timestamp":1589926651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18311666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":30,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0264410X18311666"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.08.037","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing the effectiveness of zoster vaccine live: A retrospective cohort study using primary care data in the United Kingdom","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.08.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Merck Sharp & Dohme Corp., and The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}